Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hemo OrganicBOM:524590 29 EBITDA Margin % is 0.00% as of Jun. 2026. GuruFocus rates BOM:524590 with a GF Score™ of 29/100. The stock has 8 warning signs investors should review. Among 541 Conglomerates companies, Hemo Organic ranks worse than 94.64% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Hemo Organic's EBITDA for the
three
months ended in Jun. 2026 was ₹-0.74 Mil. Hemo Organic's Revenue for the
three
months ended in Jun. 2026 was ₹0.00 Mil. Therefore, Hemo Organic's EBITDA margin for the quarter that ended in Jun. 2026 was 0.00%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Hemo Organic EBITDA Margin % Related Terms
Hemo Organic EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Hemo Organic's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:524590 vs MMM, HON: EBITDA Margin % Comparison
For the Conglomerates subindustry, Hemo Organic's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hemo Organic EBITDA Margin % vs Conglomerates Industry
For the Conglomerates industry and Industrials sector, Hemo Organic's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Hemo Organic's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hemo Organic (BOM:524590) has a EBITDA Margin % of 0.00% as of Jun. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Hemo Organic and its competitors. According to the industry distribution chart, Hemo Organic ranks #512 out of 541 companies in the Conglomerates industry, placing it in the top 94.6%.
Is Hemo Organic's EBITDA Margin % too high?
Hemo Organic's current EBITDA Margin % is 0.00%. Based on the distribution chart, Hemo Organic ranks #512 out of 541 companies in the Conglomerates industry, which is in the bottom quartile relative to peers. Overall, Hemo Organic has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Hemo Organic's EBITDA Margin % compare to MMM and HON?
According to the Conglomerates industry distribution chart, Hemo Organic ranks #512 out of 541 companies for EBITDA Margin %. This places Hemo Organic in the lower half of its industry. The industry median EBITDA Margin % is 12.08. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Conglomerates company?
The median EBITDA Margin % among Conglomerates companies is 12.08, based on 541 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Hemo Organic and its competitors. For the Conglomerates industry, the median EBITDA Margin % is 12.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hemo Organic's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hemo Organic stock overvalued right now?
Hemo Organic (BOM:524590) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Hemo Organic's overall GF Score™ is 29/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Hemo Organic (BOM:524590), the current EBITDA Margin % is 0.00% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Hemo Organic Ltd is mainly focused on trading and distribution, particularly in rice and textiles. The company buys, sells, imports, exports, and distributes agricultural commodities such as wheat, rice, maize, vegetables, and fruits at both retail and wholesale levels, maintaining high standards across domestic and international markets. Its portfolio includes wheat, rice, maize, vegetables like capsicum, tomato, green chili, onion, and potato, as well as fruits including apple, red dragon fruit, sweet lime, and pomegranate.
29GF Score
Get the complete analysis for BOM:524590
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524590 has been successfully added to your 
